From: Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Characteristic | Nonfatigued | Fatigued | P -value |
---|---|---|---|
Male (n= 222) | 54 (60.00 %) | 64(48.48 %) | 0.101 |
Age, y | 61.63 ± 9.49 | 62.50 ± 10.21 | 0.524 |
Onset age, y (n= 222) | 57.88 ± 9.77 | 57.89 ± 10.51 | 0.992 |
Duration of disease, y (n= 222) | 3.75 ± 3.26 | 4.61 ± 2.99 | 0.046* |
Education, y (n= 222) | 10.61 ± 3.12 | 9.80 ± 3.69 | 0.09 |
LEDD (mg/day) (n= 222) | 211.19 ± 263.18 | 280.24 ± 304.04 | 0.081 |
H-Y stage (n= 222) | 1.73 ± 0.78 | 2.00 ± 0.76 | 0.009* |
UPDRS total score (n= 222) | 39.43 ± 20.26 | 52.39 ± 20.19 | <0.001* |
UPDRS part I (n= 222) | 2.93 ± 1.93 | 4.19 ± 2.26 | <0.001* |
UPDRS part II (n= 222) | 9.88 ± 4.80 | 12.57 ± 5.72 | <0.001* |
UPDRS part III (n= 222) | 25.76 ± 15.37 | 33.53 ± 14.66 | <0.001* |
Postural/gait (sum of UPDRS item 27–30) | 3.28 ± 2.80 | 4.80 ± 3.07 | <0.001* |
Bradykinesia (sum of UPDRS item 23–26,31) | 12.30 ± 7.98 | 15.9 ± 7.35 | 0.001* |
Rigidity (UPDRS item 22) | 4.87 ± 4.23 | 6.45 ± 4.36 | 0.008* |
Tremor (sum of UPDRS item20 and item21) | 3.36 ± 3.26 | 3.78 ± 3.88 | 0.391 |
UPDRS IV (n= 222) | 0.86 ± 1.65 | 1.70 ± 2.57 | 0.007* |
MoCA (n= 222) | 22.87 ± 4.59 | 21.85 ± 4.27 | 0.066 |
HAMD (n= 177) | 7.26 ± 5.47 | 9.32 ± 5.17 | 0.006* |
PDSS (n= 177) | 119.10 ± 23.65 | 98.82 ± 25.74 | <0.001* |